首页> 外国专利> Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans

Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans

机译:部分冻干的1,6-二磷酸果糖(FDP),用于人体注射

摘要

A method is disclosed for preparing a partially lyophilized (freeze-dried) fructose-1,6-diphosphate (FDP) or pharmacologically acceptable salt thereof wherein an aqueous solution of FDP or salt thereof is lyophilized until a solidified material is produced have a residual water content of 10% to 25% (by weight). This high moisture content does not degrade or limit the stability or shelf life of the product. FDP preparations having residual water content in the range of 12% to 16% by weight are especially preferred. A caked, powdered, or other solidified formulation of the FDP containing less than 5% percent total impurities, and less than 1% of any one single impurity, is useful in various ways, such as (1) in an injection kit for rapid (e.g., pre-diagnostic) injection of FDP into people suffering medical crises such as heart attacks, severe blood loss, suffocation, etc, and (2) in the treatment of patients preparing to undergo circulatory bypass of the heart, during surgery.
机译:公开了一种用于制备部分冻干的(冷冻干燥的)1,6-二磷酸果糖(FDP)或其药理学上可接受的盐的方法,其中将FDP或其盐的水溶液冻干直至产生固化的材料具有残留水。含量为10%至25%(按重量计)。如此高的水分含量不会降低或限制产品的稳定性或保质期。具有残余水含量在12重量%至16重量%范围内的FDP制剂是特别优选的。 FDP的饼状,粉状或其他固化制剂含有少于5%的总杂质,且少于一种单一杂质的1%,可以多种方式使用,例如(1)用于快速(例如,对患有心脏病,严重失血,窒息等医疗危机的人进行FDP的诊断,以及(2)在手术期间准备进行心脏循环旁路治疗的患者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号